Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI ISIN · CA64119M1059 LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 336 across all filing types
Latest filing 2021-12-16 Regulatory Filings
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing an award received by Nurosene's Chief Scientific Officer for research on placebo response related to mental health. It describes the research findings, the technology platform NetraAI, and provides background information about the researchers and the company. There is no financial data, no regulatory filing references, no mention of financial results, no shareholder meeting information, no capital or financing updates, and no legal proceedings. The document is a corporate announcement focused on research recognition and company information, typical of a general regulatory announcement or press release. It does not fit into any specific financial or regulatory filing categories such as Annual Report, Earnings Release, or Management Report. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories. The document length (6918 characters) and content confirm it is not a brief report publication announcement or a certification. Confidence is high due to clear content type and absence of financial or regulatory filing elements.
2021-12-16 English
News release - English.pdf
Regulatory Filings
2021-12-13 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the extension of voluntary lock-up agreements by the company's founder and early investors. It discusses the delay in release dates for shares subject to lock-up following the company's initial public offering. There is no financial data, no detailed financial report, no earnings information, no management discussion, or other report content. The document is an announcement related to capital structure and shareholder agreements, specifically about lock-up agreements which are part of financing and capital activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 4668 characters, which is consistent with a typical announcement rather than a full report.
2021-12-10 English
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing that Nurosene Health Inc.'s CEO will present at the SNN Network Canada Virtual Event on December 9, 2021. It includes event details, company background, and forward-looking statements. There is no financial data, no detailed report, no voting results, no management changes, no earnings data, and no regulatory filing content. The document is essentially an investor presentation announcement or event announcement. Given the content and length (4268 characters), it is not a full investor presentation document but an announcement of a presentation event. Therefore, the most appropriate classification is Investor Presentation (IP) as it focuses on a presentation for investors about company strategy and market position, even though it is an announcement of the presentation rather than the presentation itself. The confidence is high because the document clearly centers on an investor-focused presentation event.
2021-12-10 English
Material change report - English.pdf
Board/Management Information Classification · 100% confidence The document is titled 'Form 51-102F3 MATERIAL CHANGE REPORT' and details a material change involving the appointment of a new Chairman of the Board. It includes information about the individual joining the Board and the resignation of the previous Chairman. The content focuses on changes in the company's board of directors. There are no financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a proxy solicitation or voting results announcement. The document is clearly about a change in senior management/board composition, which fits the category of Board/Management Information (MANG). The document length is 4375 characters, which is consistent with a detailed announcement rather than a brief notice or a full report. Therefore, the appropriate classification is MANG with high confidence.
2021-11-30 English
Business acquisition report - English.pdf
Regulatory Filings
2021-11-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.